TP53 and small cell lung carcinoma: 58/62 (94%) of patients had at least one mutation. Most of the mutations were found in TP53 (79%) and RB1 (34%).0/23 (0%) controls had genetic alterations.The presence of CNAs was associated with OS, being a potential prognostic factor and monitoring tool in SCLC patients.